NHS Framework Agreement, Branded Medicines for London and South of England

Concepts

• south of england
• runcorn
• pharmaceutical products
• nhs framework agreement
• nhs
• nhs framework
• north of england regions
• period of framework
• bevacizumab period of framework
• medicines

Location

Geochart for 1 buyers and 42 suppliers

NHS England

Drreddys Laboratories

Techdow Pharma England

Biogen

Amgen

Thornton & Ross

Merck Sharpe & Dohme

Bayer

Novo Nordisk

Daiichi Sankyo

Gedeon Richter

Teva

Roche Products

Janssen Cilag

Mylan

Allergan

Sandoz

Celltrion Healthcare

Merck Serono

Eli Lilly

Merz

Astrazeneca

Ferring Pharmaceuticals

Tetris Pharma

Profile Pharma

CST Pharma

Gilead Sciences

Chugai

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

Award Detail

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Parties Awarded to Framework https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj4/e4859nDqBoS... 03. Framework Agreement and Terms and Conditions -CM_PHR_20_5598 NHS Framework Agreement, Branded Medicines for London and South of England Template https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVio/gHNH8g8.YgK... CM_PHR_20_5598_01 - NHS Framework LONDON Branded Medicines - Tranche B Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj3/F2uf5OXU_ZC... CM_PHR_20_5598_06 - NHS Framework Midlands & East and NofE - Bevacizumab Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVit/WA7wOa57AKO... CM _PHR_20_5598_03 - NHS Framework SOUTH of England Tranche A Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj2/no32CQoP7LD... CM_PHR_20_5598_04- NHS Framework SOUTH of England - Tranche B. Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVis/kL0N6R5Ggfo... CM_PHR_20_5598_02 - NHS Framework LONDON Branded Medicines - Annual Tranche Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVix/_0ogC52eXQS... CM_PHR_20_5598_05 - NHS Framework SOUTH of England Annual Tranche Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVin/epK1hXNyTh5...